|
|
|
|
| TRADING CENTER |
39.87+0.17 / +0.43%
Sanofi Aventis (NYSE:SNY)
Prev. Close:
39.70
Open:
40.12
High:
40.12
Low:
39.76
Volume:
256,571
Volume Avg.:
1,471,100
52wk Range:
24.59 - 40.28
Market Cap (mil):
104,973.96
P/E Ratio:
21.44
Dividend Yield:
N/A
| Why Investing's Better in Bhutan - MotleyFool.com | |
| Company News for December 24, 2009 - Corporate Summary - Zacks.com | |
| FDA Licenses New Influenza Vaccine Designed Specifically for People 65 Years of Age a... - PR Newswire | |
| Zacks Analyst Blog Highlights: UBS AG, Credit Suisse Group, Sanofi-Aventis, Chattem I... - Zacks.com | |
| MedImmune recalling swine flu vaccine-FDA - Reuters | |
| This Acquisition Is Icy Hot - MotleyFool.com | |
| Sanofi Expands Presence in U.S. - Analyst Blog - Zacks.com | |
| Pfizer Swings for the Fences - MotleyFool.com | |
| Stock Market News for December 22, 2009 - Market News - Zacks.com | |
| These Two Deals Are Gifts to Investors ($) - at TheStreet.com | |
| Dow in positive territory for December - CNNMoney.com | |
| 2nd UPDATE: Sanofi Boosts Consumer Drugs Portfolio With Chattem Buy - Dow Jones | |
| Better Buy: Pfizer or GlaxoSmithKline? - MotleyFool.com | |
| Company News for December 21, 2009 - Corporate Summary - Zacks.com | |
| Sanofi-Aventis to Buy Chattem for $1.9B - at TheStreet.com |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 64.70 | 0.13 / 0.20% | 14.13 |
| PFE | Pfizer Inc | 18.60 | 0.02 / 0.11% | 15.63 |
| NVS | Novartis AG | 54.84 | 0.24 / 0.44% | 15.40 |
Short Interest Date:
Nov 30 2009
Short Interest Shares:
3,330,748
Short Interest Ratio:
2.6
Float:
n/a
Short Interest as a % of Float:
n/a
Average Daily Volume:
1,963,500
Outstanding Shares:
2,631,116,430
Sanofi-aventis was incorporated under the laws of France in 1994. It is a global pharmaceutical group, which is engaged in the research, development, manufacture and marketing of healthcare products. Its business includes two main activities: pharmaceuticals and human vaccines through sanofi ... (more)
| 2008 Revenue: | $40.1 B | Headquarters: Paris, |
| Employees: | 98,213 | CEO: Christopher Viehbacher |
| Net Income: | $6.0 B | Industry: Pharmaceuticals |
| Market Cap: | $104.5 B | Website: www.sanofi-aventis.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| SNY | 39.87 | +0.17 / +0.43% | 39.70 | 40.12 | 39.76 | Profile Chart News |
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved.
Terms under which this service is provided to you. Privacy Policy. Advertising Practices.
Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
| Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use. Intraday data is at least 20-minutes delayed. All times are ET. Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data. Fundamental data provided by Morningstar, Inc.. SEC Filings data provided by Edgar Online Inc.. Earnings data provided by FactSet CallStreet, LLC. |
